Clinical Trials Search Results

Results 1-10 of 118 for your search
Show Search Criteria
Olaparib and Cediranib Maleate in Treating Patients with Recurrent, Refractory, or Metastatic Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Female
Location: 388 locations
Radiation Therapy with or without Cisplatin in Treating Patients with Recurrent Endometrial Cancer
Status: Active
Age: Not specified
Gender: Female
Location: 335 locations
Cabozantinib and Nivolumab in Treating Patients with Advanced, Recurrent or Metastatic Endometrial Cancer
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 32 locations
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 15 locations
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158 / KEYNOTE-158)
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 12 locations
1 2 3 ... 12 Next >